MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ONC has $7,632,586K in assets. $3,503,260K in debts. $4,036,868K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
239.17%
Quick Ratio
216.72%
Cash Ratio
170.45%
Debt to Asset Ratio
45.90%
Assets Breakdown
    • Cash and cash equivalents
    • Property, plant and equipment, n...
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other payab...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
Cash and cash equivalents
4,036,868
Accounts receivable, net
863,281
Inventories, net
531,687
Prepaid expenses and other current assets
232,641
Total current assets
5,664,477
Property, plant and equipment, net
1,628,114
Operating lease right-of-use assets
140,217
2025 (remainder of year)
2,090
2026-Cost Of Sales
8,272
2026-Selling General And Administrative Expenses
67
2026
8,339
2027
8,339
2029
8,339
2030 and thereafter
28,135
Intangible assets, net
63,581
Other non-current assets
136,197
Total non-current assets
1,968,109
Total assets
7,632,586
Accounts payable
383,676
Accrued expenses and other payables
1,001,661
Tax payable
11,219
Operating lease liabilities, current portion
15,732
Research and development cost share liability, current portion
90,596
Sale of future royalty liability, current portion
52,245
Short-term debt
813,296
Total current liabilities
2,368,425
Long-term debt
139,571
Sale of future royalty liability, non-current portion
832,755
Operating lease liabilities, non-current portion
51,387
Deferred tax liabilities
47,066
Research and development cost share liability, non-current portion
0
Other long-term liabilities
64,056
Total non-current liabilities
1,134,835
Total liabilities
3,503,260
Ordinary shares, 0.0001 par value per share 1,540,975,898 and 1,387,367,704 shares issued and 1,438,083,590 and 1,387,367,704 shares outstanding as of september 30, 2025 and december 31, 2024, respectively
144
Additional paid-in capital
12,616,844
Accumulated other comprehensive loss
-101,257
Accumulated deficit
-8,386,405
Total shareholders equity
4,129,326
Total liabilities and shareholders equity
7,632,586
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

2030 and thereafter$28,135K 2029$8,339K 2027$8,339K 2026$8,339K 2026-Selling General AndAdministrative Expenses$67K 2026-Cost Of Sales$8,272K 2025 (remainder ofyear)$2,090K Other non-currentassets$136,197K Intangible assets, net$63,581K Operating leaseright-of-use assets$140,217K Property, plant andequipment, net$1,628,114K Prepaid expenses andother current assets$232,641K Inventories, net$531,687K Accounts receivable, net$863,281K Cash and cashequivalents$4,036,868K Total non-currentassets$1,968,109K Total current assets$5,664,477K Total assets$7,632,586K Total liabilities andshareholders equity$7,632,586K Total shareholdersequity$4,129,326K Total liabilities$3,503,260K Accumulated deficit-$8,386,405K Accumulated othercomprehensive loss-$101,257K Additional paid-in capital$12,616,844K Total non-currentliabilities$1,134,835K Total currentliabilities$2,368,425K Ordinary shares, 0.0001par value per share...$144K Other long-termliabilities$64,056K Deferred tax liabilities$47,066K Operating leaseliabilities, non-current...$51,387K Sale of futureroyalty liability,...$832,755K Long-term debt$139,571K Short-term debt$813,296K Sale of futureroyalty liability,...$52,245K Research and developmentcost share...$90,596K Operating leaseliabilities, current portion$15,732K Tax payable$11,219K Accrued expenses andother payables$1,001,661K Accounts payable$383,676K

BeOne Medicines Ltd. (ONC)

BeOne Medicines Ltd. (ONC)